New Product Launch: Pharmaceutical
|
3M Pharmaceuticals
Aldara (imiquimod) for the treatment of external genital warts
|
Engagement Overview:
An external communications program to complement the advertising and medical education elements of the FDA approval and launch of this first new treatment in more than a decade for external genital warts.
Media strategist and contact; advocacy group liaison creator/implementer of an awards program — Innovations in STD Education: Community Based Programs that Work — that uncovered highly creative community-based programs specifically to help reduce the incidence of sexually transmitted diseases.
Results/Highlights:
Achieved one-year sales goals in less than nine months; reached more than 342 million HCPs and consumers worldwide, including a column in Cosmopolitan headlined “Aldara: New Wonder Drug for Genital Warts” and a full-page editorial in JAMA that complimented 3M Pharmaceuticals, Aldara and its Innovations in STD Education program; and there were no negative articles or commentaries about the company or its new drug.
|
|